Introduction
Hypertensive disorders of pregnancy (HDP) represent a group of conditions associated with high blood pressure during pregnancy, proteinuria and in some cases convulsions. The most serious consequences for the mother and the baby result from pre-eclampsia and eclampsia. These are associated with vasospasm, pathologic vascular lesions in multiple organ systems, increased platelet activation and subsequent activation of the coagulation system in the micro-vasculature 1 . Eclampsia is usually a consequence of pre-eclampsia consisting of central nervous system seizures which often leave the patient unconscious; if untreated it may lead to death. The long-term sequelae of both preeclampsia or eclampsia are not well evaluated, and the burden of hypertensive disorders of pregnancy stems mainly from deaths.
In the GBD 1990 hypertensive disorders of pregnancy ranked 75 th in terms of DALYs and were responsible for 6% of the burden of all maternal conditions. It was estimated that deaths due to hypertensive disorders of pregnancy represented 13% of all maternal deaths. This draft paper summarises the data and methods used to produce the Version 2 estimates of burden of hypertensive disorders of pregnancy for the year 2000.
Case and sequelae definitions
The classification of HDP is difficult because of limited knowledge about its etiology and the lack of conformity of definitions 1 . A WHO Study Group recommended the definitions listed in Table 2 .1. Further amendments to these definitions have been made by the American College of Obstetricians and Gynaecologists, particularly for clinical purposes 2 . According to these, pre-eclampsia superimposed is likely in women with hypertension alone who develop new proteinuria, or in women with pre-existing hypertension and proteinuria who have sudden increase in blood pressure or proteinuria, thrombocytopenia, or increases in hepatocellular enzymes. 
Incidence
Assessing the epidemiology of pre-eclampsia is difficult due to lack of conformity of the definitions described above. There may also be measurement bias and errors in the ascertainment of both hypertension and proteinuria. Because uniform diagnostic criteria are not always followed by those who study and report on hypertensive disorders of pregnancy, reported incidence may not be readily comparable between sites 1 .
As a result, incidence of pre-eclampsia and eclampsia was based on a systematic review by Villar et al. (unpublished) in which only studies where investigators made efforts to control and/or assure the diagnosis of pre-eclampsia and eclampsia (blood pressure and proteinuria measurements, documentation of seizure, etc.) were included. Some studies lacking details of diagnostic quality assessment, but whose data demonstrated overall good quality were also included. The data included in the review was population based and came from recently published reports as well as a series of large recent data sets available to WHO. Estimates of incidence were stratified into data from developing countries and more developed countries.
The pooled incidence of pre-eclampsia for developing countries was estimated to be 3.4%. This figure was used for all WHO sub-regions B through to E. Two developed country studies were included in the review for the incidence of pre-eclampsia. The incidence of pre-eclampsia was estimated at 2.8% from the Norwegian Birth Registry for the period 1967-1998. The South East Thames Study estimated pre-eclampsia incidence to be 0.4% for the period 1997-1998. A pooled incidence rate was not estimated as it was not possible to disaggregate the Norwegian study by year. The 0.4% incidence rate estimate from the South East Thames Study was therefore used as the estimate of pre-eclampsia incidence for all WHO A sub-regions.
Incidence for eclampsia from the systematic review was 2.3% of pre-eclampsia cases for developing regions and 0.8% of pre-eclampsia cases for developed regions. 
Time trends in hypertensive disorders of pregnancy
An assessment of the time trends of hypertensive disorders of pregnancy is difficult, due to lack of consensus about the definitions used. Eclampsia is easier to recognise and incidence surveys have been undertaken in England and Wales since 1922; these show a continuous decline in both incidence and deaths from the condition 1 . As the incidence of eclampsia is influenced by the availability and quality of antenatal care 1 , eclampsia mortality remains important in settings of high maternal mortality 3 . Epidemiological studies conducted during the last decade show no decline in the incidence of eclampsia in developing countries, suggesting an urgent need to better identify women at risk and to improve access to treatment.
Risk factors for the development of hypertensive disorders of pregnancy
Several risk factors have been found to be associated with an increased risk of developing preeclampsia: the presence of type 1 diabetes, gestational diabetes, twin birth and obesity (body mass index >29) 4 . The likelihood of progression from gestational hypertension to pre-eclampsia may be increased by a prior miscarriage 5, 6 . A study on a large cohort of Latin American and Caribbean women identified the following risk factors for developing pre-eclampsia: nulliparity, multiple pregnancy, history of chronic hypertension, gestational diabetes, maternal age over 35 years, fetal malformation and obesity 7 . Using the same source of data (the Latin American and Caribbean Perinatal System database) Conde-Agudelo et al. showed that interpregnancy intervals longer than 59 months are associated with an increased risk of pre-eclampsia and eclampsia Error! Bookmark not defined. .
Mortality and case fatality
Although eclampsia is responsible for the majority of deaths associated with hypertensive disorders of pregnancy, death can occur in the absence of convulsions 1 . Evidence on case fatality rates of eclampsia is limited to mainly hospital-based studies (table 4.1) where rates are likely to be higher.
As for other maternal conditions, deaths due to hypertensive disorders of pregnancy were estimated using a proportional mortality model. A first set of regional estimates of total number of maternal deaths have been produced using the methodology developed for WHO/UNICEF 1995 estimates of maternal mortality 8 . Available information on cause of death distributions in each region, including data from vital registration systems 9 , were then used to estimated the proportion of different causes of maternal mortality 10 . Table 4 .2 presents available data on the proportion of deaths due to eclampsia among all maternal deaths.
Based on this evidence, the GBD 2000 study estimates the following case fatality rates for hypertensive disorders of pregnancy (Table 4. 3). As discussed above, case fatality reports from hospital-based studies may be biased due to a selected high risk population. 
Disease model for hypertensive disorders of pregnancy
A disease model was developed for hypertensive disorders of pregnancy as described in figure 5.1. During pregnancy, delivery or shortly thereafter (within 6 weeks), women with hypertensive disorders of pregnancy may have renal or liver damage, pulmonary oedema and cerebral haemorrhage. However, no long-term follow-up studies have been performed to evaluate the consequences of eclampsia over time. A retrospective study at the King Edward VIII hospital in Durban, South Africa, identified 140 cases of neurological complication during pregnancy among 14,881 deliveries within one year 17 . All but one of these cases had eclampsia, and all of them recovered completely before discharge. A study from Norway using record linkage from 2 registers between 1967 and 1992, the national medical birth register and the national register of causes of death, showed that women who had pre-eclampsia may have an increased risk of death from cardiovascular causes in later life than non-pre-eclamptic women 18 . In the GBD 2000 neurological complications were therefore no longer considered as sequelae of eclampsia and pre-eclampsia. Long-term follow-up studies are needed to evaluate the extent to which women with hypertensive disorders of pregnancy and particularly eclampsia, will develop long-term complications. 
Global burden of hypertensive disorders of pregnancy in 2000
General methods used for the estimation of the global burden of disease are given elsewhere 19 . The tables and graphs below summarise the global burden of hypertensive disorders of pregnancy estimates for the GBD 2000 and compare them with the hypertensive disorders of pregnancy estimates from the GBD 1990 20 . 
Conclusions
These are Version 3 estimates f or the GBD 2000. Apart from the uncertainty analysis, updating estimates to reflect revisions of mortality estimates and any new or revised epidemiological data or evidence, it is not intended to undertake any major addition revision of these estimates.
We welcome comments and criticisms of these draft estimates, and information on additional sources of data and evidence. Please contact Colin Mathers (Evidence and Information for Policy, WHO Geneva) on email mathersc@who.int.
